NCT04705987View on ClinicalTrials.gov

Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure

PHASE3CompletedINTERVENTIONAL

Enrollment

279

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

May 17, 2024

Study Completion Date

May 17, 2024

Conditions

HEART FAILURE

Interventions

DRUG

Colchicine 0.5 MG

Colchicine 0.5 mg/24h Treatment 8 weeks

DRUG

Placebo

Placebo 1c/24h Treatment 8 weeks

Trial Locations (1)

30120

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

All Listed Sponsors

lead

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

OTHER

NCT04705987 - Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure | Biotech Hunter | Biotech Hunter